Contact
Please use this form to send email to PR contact of this press release:
Soricimed Granted Orphan-Drug Designation from the U.S. FDA for Treatment of Ovarian Cancer
TO:
Please use this form to send email to PR contact of this press release:
Soricimed Granted Orphan-Drug Designation from the U.S. FDA for Treatment of Ovarian Cancer
TO: